The Medicines Company (MDCO)
-NasdaqGS 33.76 
1.01(3.08%) May 2, 4:00PM EDT|After Hours
:
33.77 0.01 (0.02%) May 2, 4:45PM EDT
| Prev Close: | 32.75 |
|---|
| Open: | 33.00 |
|---|
| Bid: | 32.44 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 36.30 |
|---|
| Beta: | 0.93 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 32.76 - 33.93 |
|---|
| 52wk Range: | 20.04 - 34.95 |
|---|
| Volume: | 735,516 |
|---|
| Avg Vol (3m): | 715,853 |
|---|
| Market Cap: | 1.80B |
|---|
| P/E (ttm): | 57.41 |
|---|
| EPS (ttm): | 0.59 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Alternative Generic Drug Products to Sustain Decent Margins and Cash Flow Generation Over the Long Term: Expert Analyst David Amsellem Discusses the Generic Drug Space with The Wall Street TranscriptWall Street Transcript(Thu, May 2)
- 2 Healthcare Stock Winners and 3 Losers After Earnings Are Digestedat Wall St. Cheat Sheet(Sun, Apr 28)
- Earnings Increase at The Medicines Co.Zacks(Fri, Apr 26)
- Cerner Raises Outlook On Stable Hospital Spendingat Investor's Business Daily(Fri, Apr 26)
- Chuck Royce Buys Stifel Financial, Tidewater, Alamos, Sells Kennametal, Gardner Denver, Gartnerat Forbes(Thu, Apr 25)
- Biotechs Near Highs In A Week Of Key Earnings Reportsat Investor's Business Daily(Wed, Apr 24)
- Medicines Co. Earnings Top Views; New Drugs Awaitat Investor's Business Daily(Wed, Apr 24)
- The Medicines Company's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, Apr 24)
- Medicines Co. Beats Q1 Profit Estimates; Stock Slipsat Investor's Business Daily(Wed, Apr 24)
- Medicines Co. Earnings: Here’s Why Shares are Down Nowat Wall St. Cheat Sheet(Wed, Apr 24)
- The Medicines Company Earnings Call scheduled for 8:30 am ET todayCCBN(Wed, Apr 24)
- The Medicines Company Reports First Quarter 2013 Financial ResultsMarketwired(Wed, Apr 24)
- Q1 2013 The Medicines Company Earnings Release - Before Market OpenCCBN(Wed, Apr 24)
- MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Wed, Apr 24)
- Stocks Pull Back Late Session; Apple, Panera Earnings On Tapat Investor's Business Daily(Tue, Apr 23)
Key Statistics
| Forward P/E (1 yr): | 22.21 |
|---|
| P/S (ttm): | 2.97 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.93 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.34 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | 0.75 |
|---|
Business Summary
The Medicines Company provides medical solutions for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients ...
View More